Kansas City Precision Oncology Conference
Overview
This accredited continuing education activity, Kansas City Precision Oncology Conference, is designed to improve the care of cancer patients by educating cancer care providers about precision oncology. This oncology conference features leading experts in the field of precision oncology who will provide a comprehensive overview of the implications of actionable molecular alterations across common malignancies.
This activity is designed to facilitate learning, improve knowledge retention, and inspire participants to implement the newly acquired knowledge into their clinical practice. Through didactic lectures, case-based discussions, and interactive questions and answer sessions, participants will be able to ask relevant questions, clarify concerns, and network with expert faculties.
Target Audience
- Hematologists/ Oncologists
- Oncology Fellows
- NPs/PAs
- Pharmacists
- Nurses
- Researchers and others
ORGANIZING COMMITTEE:
Course Director:
Binay Shah, MD, MHA - Binaytara Foundation
Conference Chair:
Anup Kasi, MD, MPH - University of Kansas Medical Center
Learning Objectives
Upon successful completion of this educational activity, participants will be able to:
- Identify common molecular abnormalities across several prevalent malignancies and review the appropriate timing of testing to detect these abnormalities.
- Interpret results of next-generation sequencing and other predictive biomarkers to assess responses to targeted therapies, while recognizing associated challenges.
- Describe the role, including advantages and limitations, of various testing methodologies available for selecting targeted therapies.
- Develop optimal molecular-targeted treatment strategies for the management of patients with cancer.
- Summarize emerging research, mechanisms of action, and roles of novel molecular-targeted therapies in the clinical investigation of cancer patients.
HOTEL INFORMATION
Embassy Suites by Hilton Kansas City International Airport
7640 NW Tiffany Springs Pkwy
Kansas City, MO 64153
United States
GLOBAL ONCOLOGY PROJECT
Click this link to learn more about our ongoing project building a 200-bed cancer hospital in Nepal: https://binayfoundation.org/cancer-hospital/
Program
Saturday, March 8, 2025
All times are listed in Central Standard Time (CST)
07:00 AM – 08:00 AM Registration, Breakfast, & Exhibits
08:00 AM – 08:05 AM Welcome
08:05 AM – 08:25 AM Binaytara Foundation's Efforts in Improving Cancer Care Disparities - Justine Kam
08:25 AM – 09:45 AM Session 1 - Precision Oncology - General Concepts
Session Chair: Wei Zhang, MD, PhD
08:25 AM – 08:45 AM Ct-DNA in Clinical Practice: Current Standards and Emerging Roles - Weijing Sun, MD, FACP
08:45 AM – 09:05 AM Updates on Germline Testing for Hereditary Cancer Syndromes - Jordyn Koehn, MS, CGC
09:05 AM – 09:45 AM Case-Based Discussion: Melanoma and Lynch Syndrome - Nina S Mathew, MD; Elizabeth Countee, MS, CGC
09:45 AM – 10:15 AM Break & Exhibits
10:15 AM – 10:55 AM Session 2 - GI Oncology
Session Chair: Anup Kasi, MD, MPH
10:15 AM – 10:35 AM Genomics in GI Cancers - Anup Kasi, MD, MPH
10:35 AM – 10:55 AM Case-Based Discussion: Targeted Therapies and Immunotherapy in GI Cancers - Marc T. Roth, MD; Jaswinder Singh, MD; Manidhar Lekkala, MD
10:55 AM – 11:35 AM Session 3 - Breast Cancer
Session Chair: Qamar J. Khan, MD
10:55 AM – 11:15 AM Genomics in Breast Cancer - Yiduo Hu, MD, PhD
11:15 AM – 11:35 AM Case-Based Discussion - Whitney L. Hensing, MD; Kelly C. Gast, MD
11:35 AM – 12:35 PM Lunch & Exhibits
12:35 PM – 01:15 PM Session 4 - GU Oncology
Session Chair: Rahul A. Parikh, MD, PhD
12:35 PM – 12:55 PM Genomics in GU Cancer - Haoran Li, MD, PhD
12:55 PM – 01:15 PM Case-Based Discussion - Vinay Gupta, MD; Saqib H Abbasi, MD
01:15 PM – 01:55 PM Session 5 - Lung Cancer
Session Chair: Chao H. Huang, MD FACP
01:15 PM – 01:35 PM Genomics in Lung Cancer - Jun Zhang, MD, PhD
01:35 PM – 01:55 PM Case-Based Discussion: Lung Cancer - Anusha Chidharla, MD; Vinay Raja, MD; Sreekanth Donepudi, MD
01:55 PM – 02:20 PM Break & Exhibits
02:20 PM – 03:20 PM Session 6 - Hematology
Session Chair: Al-Ola Abdallah, MD
02:20 PM – 02:40 PM Multiple Myeloma - Nausheen Ahmed, MD
02:40 PM – 03:00 PM Myeloid Disorders - Abdulraheem Yacoub, MD
03:00 PM – 03:20 PM Case-Based Discussion: Lymphoma - Marc S. Hoffmann, MD; Aung Tun, MD
03:20 PM Adjourn
Venue
Faculty
IDENTIFICATION AND MITIGATION OF POTENTIAL CONFLICT OF INTERESTS:
All conflict of interest has been identified and mitigated for individuals in control of contents.
PLANNING COMMITTEE DISCLOSURE STATEMENT:
None of the members of the planning committee, nor any member of their immediate families, have a relevant financial interest in or affiliation with any commercial supporter of this educational activity and/or with the manufacturer(s) of commercial products and/or providers of any commercial services discussed in this educational activity.
Anup Kasi, MD MPH
Al-Ola Abdallah
Chao Huang
Qamar Khan
Rahul Parikh, MBBS, PhD
Wei Zhang, MD, PhD
Saqib Abbasi
Nausheen Ahmed, MD
Anusha Chidharla, MD
Elizabeth Countee, MS, CGC
vinay gupta
Whitney Hensing, MD, MSCR
Marc Hoffmann, Associate Professor; Director, Lymphoma Program
Yiduo Hu, PhD, MD
Jordyn Koehn, ABGC Certified Genetic Counselor
Haoran Li
Nina Mathew
VINAY RAJA, MD
Marc Roth, MD
Weijing Sun
Aung Tun
Abdulraheem Yacoub, MD
Jun Zhang, MD, PhD
SREEKANTH DONEPUDI, MD, MP
Kelly Gast, MD
Manidhar Lekkala, MD
Accreditation
Acknowledgement of Commercial Support
This activity is supported with an Independent Medical Education grant from AstraZeneca.
ACPE Accreditation Statement
The Binaytara Foundation is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
The ACPE Universal Activity Number assigned to the activity is 0686-0000-25-003-L01-P.
The Binaytara Foundation designates this activity for a maximum of 5 pharmacy CEUs.
Participants must pass the post-test, complete course evaluation, and provide their NABP e-Profile ID number (ePID) and Date of Birth (MMDD) to Binaytara foundation within 30-days of participating in the activity. Participants who do not complete these requirements within 30-days of participating in the live activity will not be awarded the CEUs.
The Binaytara foundation may distribute a participation certificate containing information provided to NABP from the Accreditation Council for Pharmacy Education (ACPE) via CPE Monitor®. ACPE policy states paper and/or electronic statements of credit may no longer be distributed directly to learners as proof of ACPE credit. The official record of credit may be located in the learner’s e-profile in CPE Monitor®.”
Available Credit
- 5.00 ABIM MOC IISuccessful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 5.00 Medical Knowledge points in the American Board of Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
- 5.00 ACPE Pharmacy
The Binaytara Foundation is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
The ACPE Universal Activity Number assigned to the activity is
Participants must pass the post-test, complete course evaluation, and provide their NABP e-Profile ID number (ePID) and Date of Birth (MMDD) to Binaytara Foundation within 30-days of participating in the activity. Participants who do not complete these requirements within 30-days of participating in the Live activity will not be awarded the CEUs.
The Binaytara foundation may distribute a participation certificate containing information provided to NABP from the Accreditation Council for Pharmacy Education (ACPE) via CPE Monitor®. ACPE policy states paper and/or electronic statements of credit may no longer be distributed directly to learners as proof of ACPE credit. The official record of credit may be located in the learner’s e-profile in CPE Monitor®.
After CPE units are processed by ACPE and NABP, pharmacists and pharmacy technicians will be able to login to a comprehensive electronic profile to access information about their completed CPE and Certificate Programs.
- 5.00 AMA PRA Category 1 Credit™The Binaytara Foundation is accredited by the Washington State Medical Association to provide continuing medical education for physicians. The Binaytara Foundation designates this live activity for a maximum of 5.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. This activity meets the criteria for up to 5.00 hours of Category I CME credit to satisfy the relicensure requirements of the Washington State Medical Quality Assurance Commission.
- 5.00 Nursing Contact HoursProvider approved by the California Board of Registered Nursing, Provider # CEP17035, for 5.00 Contact Hours.
Exhibitors
If you are interested in exhibiting at this meeting, please visit our exhibit page here - https://education.binayfoundation.org/exhibit-information
Register/Take course
Price
POLICY ON INDUSTRY EMPLOYEE'S PARTICIPATION IN MARKETING/EDUCATION ACTIVITY AT THE CONFERENCE:
All marketing and product promotion activities must occur in the designated exhibit hall or product theater space separate from the area where this accredited continuing education takes place.
The exhibit and product promotion space is reserved only for companies that have purchased marketing and product promotion slots at the conference. The individual registration fee doesn't include marketing or product theater privileges. Please refer to the sponsorship handbook for the types of marketing activities included in your display/sponsorship fees.
If your company has NOT purchased a marketing opportunity such as an exhibit table, product theater slot or another type of marketing opportunity, you may not participate in any marketing activity or attempt to educate healthcare providers about your product or service. Industry attendees of companies without marketing opportunities must refrain from interacting with healthcare providers at this meeting in any form, including introducing themselves as an employee of the company, discussing the care of patients, handing out flyers and brochures, inviting participants to the company's other programs, etc.
Violating this policy will result in a fine equivalent to a general display fee for that conference.
NOTICE TO HCPS EMPLOYED BY THE INDUSTRY:
If you are employed by industry, including pharmaceuticals and biotech companies, you must pay the INDUSTRY REGISTRATION FEE to participate in any meeting organized by the Binaytara Foundation. If you misrepresented yourself as a healthcare provider not employed by the industry and failed to pay the Industry registration fee, the following fees apply:
- If your company has purchased a display table at the event, you will be billed the full INDUSTRY REGISTRATION FEE plus a fine equivalent to the full industry registration fee for that event = 2 X the industry registration fee.
- If your company has NOT purchased a display table at the event AND you attended the meeting without paying a full industry registration fee, you will be billed a full GENERAL DISPLAY FEE for that event.
- If your company has NOT purchased a display table at the event AND you attended the meeting paying a full industry registration fee, BUT YOU PARTICIPATED IN MARKETING AND PROMOTIONAL ACTIVITIES, you will be billed a full GENERAL DISPLAY FEE for that event.
Any outstanding display fee, registration fee, and fines must be paid before the industry employee or the company will be able to attend/display at our conferences again.
CANCELLATION POLICY
You may cancel your enrollment at any time. Cancellation fees apply as below:
- 50% of the paid registration fee will be refunded if registration is canceled six weeks before the conference.
- No refunds will be issued if registration is canceled after that date.
No credits will be offered if you do not complete all required steps of this activity, including registration and participation in the live meeting.
Required Hardware/software
Morbi tristique senectus et netus et malesuada fames ac turpis.